Xinyi Leng1, Hui Fang2, Thomas W H Leung1, Chen Mao3, Zhongrong Miao4, Liping Liu4, Ka Sing Wong1, David S Liebeskind5. 1. Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong. 2. Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. 3. Division of Epidemiology, the Hong Kong Branch of the Chinese Cochrane Center, School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong. 4. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. 5. Department of Neurology, Neurovascular Imaging Research Core, University of California Los Angeles, Los Angeles, California, USA.
Abstract
OBJECTIVE: We aimed to investigate the role of pretreatment collateral status in predicting the efficacy and safety of endovascular treatment (EVT) in acute ischaemic stroke due to cervical and/or cerebral arterial occlusions. METHODS: Relevant full-text articles published since 1 January 2000, investigating correlations between collateral status and any efficacy or safety outcome in patients undergoing EVT in cohort or case-control studies, or randomised clinical trials, were retrieved by PubMed and manual search. Two authors extracted data from eligible studies and assessed study quality. Risk ratios (RR) were pooled for good versus poor collaterals for outcomes based on a random-effects model. Sensitivity and subgroup analyses were conducted. RESULTS: In total, 35 (3542 participants) and 23 (2652 participants) studies were included in qualitative review and quantitative meta-analysis, respectively. Overall, good pretreatment collaterals increased the rate of favourable functional outcome at 3 months (RR=1.98, 95% CI 1.64 to 2.38; p<0.001), and reduced the risks of periprocedural symptomatic intracranial haemorrhage (RR=0.59, 95% CI 0.43 to 0.81; p=0.001) and 3-month mortality (RR=0.49, 95% CI 0.38 to 0.63; p<0.001), as compared with poor collaterals, in patients with acute ischaemic stroke under EVT. No individual study could alter the estimate of overall effect of collateral status, but there were moderate to significant heterogeneities between subgroups of studies with different modes of EVT, different arterial occlusions and different collateral grading methods. CONCLUSIONS: Good pretreatment collateral status is associated with higher rates of favourable functional outcome, and lower rates of symptomatic intracranial haemorrhage and mortality, in patients with acute ischaemic stroke receiving endovascular therapies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVE: We aimed to investigate the role of pretreatment collateral status in predicting the efficacy and safety of endovascular treatment (EVT) in acute ischaemic stroke due to cervical and/or cerebral arterial occlusions. METHODS: Relevant full-text articles published since 1 January 2000, investigating correlations between collateral status and any efficacy or safety outcome in patients undergoing EVT in cohort or case-control studies, or randomised clinical trials, were retrieved by PubMed and manual search. Two authors extracted data from eligible studies and assessed study quality. Risk ratios (RR) were pooled for good versus poor collaterals for outcomes based on a random-effects model. Sensitivity and subgroup analyses were conducted. RESULTS: In total, 35 (3542 participants) and 23 (2652 participants) studies were included in qualitative review and quantitative meta-analysis, respectively. Overall, good pretreatment collaterals increased the rate of favourable functional outcome at 3 months (RR=1.98, 95% CI 1.64 to 2.38; p<0.001), and reduced the risks of periprocedural symptomatic intracranial haemorrhage (RR=0.59, 95% CI 0.43 to 0.81; p=0.001) and 3-month mortality (RR=0.49, 95% CI 0.38 to 0.63; p<0.001), as compared with poor collaterals, in patients with acute ischaemic stroke under EVT. No individual study could alter the estimate of overall effect of collateral status, but there were moderate to significant heterogeneities between subgroups of studies with different modes of EVT, different arterial occlusions and different collateral grading methods. CONCLUSIONS: Good pretreatment collateral status is associated with higher rates of favourable functional outcome, and lower rates of symptomatic intracranial haemorrhage and mortality, in patients with acute ischaemic stroke receiving endovascular therapies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Wojciech Rzechorzek; Hua Zhang; Brian K Buckley; Kunjie Hua; Daniel Pomp; James E Faber Journal: J Cereb Blood Flow Metab Date: 2017-07-07 Impact factor: 6.200
Authors: Anna Mm Boers; Ivo Gh Jansen; Olvert A Berkhemer; Albert J Yoo; Hester F Lingsma; Cornelis H Slump; Yvo Bwem Roos; Robert J van Oostenbrugge; Diederik Wj Dippel; Aad van der Lugt; Wim H van Zwam; Henk A Marquering; Charles Blm Majoie Journal: J Cereb Blood Flow Metab Date: 2016-11-19 Impact factor: 6.200
Authors: Manoj Jagani; Waleed Brinjikji; Mohammad H Murad; Alejandro A Rabinstein; Harry J Cloft; David F Kallmes Journal: J Vasc Interv Neurol Date: 2017-01
Authors: Adam de Havenon; Michael Mlynash; May A Kim-Tenser; Maarten G Lansberg; Thalabe Leslie-Mazwi; Soren Christensen; Ryan A McTaggart; Matthew Alexander; Gregory Albers; Joseph Broderick; Michael P Marks; Jeremy J Heit Journal: Stroke Date: 2019-03 Impact factor: 7.914
Authors: T Hashimoto; T Kunieda; T Honda; F Scalzo; L Ali; J D Hinman; N M Rao; M Nour; M Bahr-Hosseini; J L Saver; R Raychev; D Liebeskind Journal: AJNR Am J Neuroradiol Date: 2021-11-18 Impact factor: 3.825
Authors: Seyedmehdi Payabvash; Nils H Petersen; Khalid Al-Dasuqi; Gerardo A Torres-Flores; Sumita M Strander; Cindy Khanh Nguyen; Krithika U Peshwe; Sreeja Kodali; Andrew Silverman; Ajay Malhotra; Michele H Johnson; Charles C Matouk; Joseph L Schindler; Lauren H Sansing; Guido J Falcone; Kevin N Sheth Journal: Stroke Date: 2020-08-12 Impact factor: 7.914